Trinity Biotech TRIB Q4 2024 Earnings Deep EPS Miss Weighs on Investor Sentiment CTSH Q1 2026 Earnings EPS Beat Drives Modest Stock Gain MSAI Q1 2026 Earnings EPS Surprise Beats Estimates Stock Rises Amid Revenue Uncertainty FOXA Q1 2026 Earnings EPS Beat by Over 33 Drives Positive Market Reaction EGBN Q1 2026 Earnings EPS Surpasses Estimates by Over 43 RLMD Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Continues RD Investment